Literature DB >> 16141263

The emerging role of inflammation in atrial fibrillation and the potential of anti-inflammatory interventions.

Panagiotis Korantzopoulos, Theofilos M Kolettis, Konstantinos Siogas, John A Goudevenos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141263     DOI: 10.1093/eurheartj/ehi450

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Selective molecular potassium channel blockade prevents atrial fibrillation.

Authors:  Guy Amit; Kan Kikuchi; Ian D Greener; Lizhu Yang; Victor Novack; J Kevin Donahue
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 2.  Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 3.  Interdependent Relationship Between Atrial Fibrillation and Sinus Rhythm at the Hypothetical Interface of Atrial Fibrillation, Autonomic Tone, Sinoatrial Node and Inflammation : Analytical Review, Reconsiderations, Speculations and New Insights.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2012-12-16

4.  Preclinical efficacy and safety of KCNH2-G628S gene therapy for postoperative atrial fibrillation.

Authors:  Zhao Liu; Julie A Hutt; Barur Rajeshkumar; Yoshihiro Azuma; Kailai L Duan; J Kevin Donahue
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-23       Impact factor: 5.209

Review 5.  Managing atrial fibrillation in the very elderly patient: challenges and solutions.

Authors:  Nikolaos Karamichalakis; Konstantinos P Letsas; Konstantinos Vlachos; Stamatis Georgopoulos; Athanasios Bakalakos; Michael Efremidis; Antonios Sideris
Journal:  Vasc Health Risk Manag       Date:  2015-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.